Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yezhou Ding"'
Autor:
Shike Lou, Xiaoyin Wang, Fei Yuan, Gangde Zhao, Mingyang Feng, Yezhou Ding, Lanyi Lin, Kehui Liu, Xiaolin Wang, Wanqing Chi, Hui Wang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
This study investigated the potential of immune checkpoint inhibitors (ICIs) combined with chemotherapy as a promising treatment approach for malignancies. This report focuses on a patient with drug-induced liver injury (DILI) following the administr
Externí odkaz:
https://doaj.org/article/a1cc9b01e6e44e138b308e962bed9d49
Autor:
Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao, Shisan Bao, Hui Wang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Aim: To analyze the safety of immune checkpoint inhibitors in primary liver cancer patients and to identify the risk factors for immune-related adverse events (irAEs).Methods: The study enrolled 106 patients with primary liver cancer, including 81 wi
Externí odkaz:
https://doaj.org/article/be93bbaabd00471ab2a33a0cf5ff268d
Autor:
Yezhou Ding, Mingyang Feng, Di Ma, Gangde Zhao, Xiaolin Wang, Baoyan An, Yumin Xu, Shike Lou, Lanyi Lin, Qing Xie, Kehui Liu, Shisan Bao, Hui Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe clinical characteristics of primary liver cancer (PLC) patients are changing, maybe due to hepatitis viral vaccination and lifestyle changes, etc. The linkage between these changes and outcomes among these PLCs has not yet been fully el
Externí odkaz:
https://doaj.org/article/87663128b2e848ffaafdda2a6b986ec2
Autor:
Kehui Liu, Yezhou Ding, Yumin Xu, Weiliang Tang, Mingyang Feng, Yunye Liu, Shisan Bao, Hui Wang
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Immunoglobulin light chain (AL) amyloidosis commonly affects the kidney or heart, but may also involve the liver at a histopathological level. Early diagnosis of AL amyloidosis is important for proper management with desirable out
Externí odkaz:
https://doaj.org/article/01608ea6f06544d994fda30444ca6eb3
Autor:
Yezhou Ding, Kehui Liu, Yumin Xu, Qingqing Zhao, Shike Lou, Xiaogang Xiang, Lei Yan, Zhujun Cao, Qing Xie, Chuanwu Zhu, Shisan Bao, Hui Wang
Publikováno v:
Cancer Medicine, Vol 9, Iss 9, Pp 3057-3069 (2020)
Abstract Background Alpha‐fetoprotein (AFP), routinely used for diagnosis of hepatocellular carcinoma (HCC), is limited with relatively low sensitivity and high false positivity in HBV‐related HCC (HBV‐HCC). Thus, an alternative approach was ex
Externí odkaz:
https://doaj.org/article/75536a75d27747c980434806427a3496
Autor:
Liwen Chen, Zhujun Cao, Lei Yan, Yezhou Ding, Xinghua Shen, Kehui Liu, Xiaogang Xiang, Qing Xie, Chuanwu Zhu, Shisan Bao, Hui Wang
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Background and AimsNecroptosis is a newly identified type of cell death with programmed pathways. The current study was performed to investigate necroptosis by measuring its key regulators; receptor interacting protein kinase 3 (RIPK3) and mixed line
Externí odkaz:
https://doaj.org/article/cd6dc1ef369b4a939231d82d3be3ec1d
Autor:
Yumin Xu, Zhujun Cao, Yezhou Ding, Ziqiang Li, Xiaogang Xiang, Rongtao Lai, Zike Sheng, Yuhan Liu, Wei Cai, Ronggui Hu, Hui Wang, Qing Xie
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
BackgroundLong non-coding RNAs (lncRNAs) have recently been tightly linked to plenty of human diseases. However, knowledge of acute-on-chronic liver failure (ACLF) related lncRNAs remains insufficient. In this work, we studied the role of the lncRNA
Externí odkaz:
https://doaj.org/article/8cf7942107744117a47fea2c8a7d5a4f
Autor:
Lei Yan, Hui Wang, Xiaogang Xiang, Qing Xie, Yezhou Ding, Kehui Liu, Shisan Bao, Qingqing Zhao, Shike Lou, Zhujun Cao, Chuanwu Zhu, Yumin Xu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 9, Pp 3057-3069 (2020)
Cancer Medicine, Vol 9, Iss 9, Pp 3057-3069 (2020)
Background Alpha‐fetoprotein (AFP), routinely used for diagnosis of hepatocellular carcinoma (HCC), is limited with relatively low sensitivity and high false positivity in HBV‐related HCC (HBV‐HCC). Thus, an alternative approach was explored to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47667e30df4540d8da6caf487dd96f0
https://doi.org/10.1002/cam4.2968
https://doi.org/10.1002/cam4.2968
Autor:
Shike Lou, Xiaolin Wang, Fei Yuan, Gangde Zhao, Lanyi Lin, Yezhou Ding, Kehui Liu, Qing Xie, Shisan Bao, Hui Wang
Immune checkpoint inhibitors (ICIs) are mAbs against cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed death-1 receptor (PD-1) and programmed death-ligand 1 (PD-L1), which the inhibitory pathways that leads to T cell inactivation. Here, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::861af16f8d668f51ce39da6e7d550ff0
https://doi.org/10.21203/rs.3.rs-1224141/v1
https://doi.org/10.21203/rs.3.rs-1224141/v1
Autor:
Qing Xie, Lei Yan, Hui Wang, Yezhou Ding, Yun Wang, Y. Liu, Jingdong Xie, Qingqing Zhao, Shisan Bao, Kehui Liu, Wei Cai
Background IL34 involves in host immunity regulated carcinogenesis. Alpha-fetoprotein (AFP) is related to the development of HCC. We explored if combination of IL-34 and APF could improve the diagnostic value in HBV related hepatocellular carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e004193eddacaea7782ad4adba2c6f
https://doi.org/10.21203/rs.3.rs-933235/v1
https://doi.org/10.21203/rs.3.rs-933235/v1